Beta
3362

Heat Shock Protein 27(HSP27) in Kidney Disease: Potentials for Diagnosis and Therapy

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

The small HSP27 is an actin-specific molecular chaperone involved in cytoskeleton architecture, cell migration, metabolism, survival, growth/differentiation, mRNA stabilization, and tumor progression. HSP27 is detected in nearly all cells with different expression levels. A variety of stimuli induce expression and/or phosphorylation of HSP27. HSP27 phosphorylation affects some of its cellular functions as phosphorylation affects HSP27 oligomerization, which in turn has an impact on some of HSP27 functions. HSP27 has been involved in different kidney diseases playing protective and counter-protective roles. HSP27 shows a protective role against several stressors as reactive oxygen species, hypoxia, osmotic stressors, etc. HSP27 and phospho-HSP27 protein levels are increased in stressed and diseased cells.  The current review presents HSP27 in the pathogenesis of different kidney diseases as renal injury, fibrosis and renal cell carcinoma, highlights its role as a potential biomarker and offers new therapeutic optionsthrough manipulation of HSP27.

DOI

10.21608/aprh.2017.3362

Keywords

HSP27, Kidney disease, protective, Stress

Authors

First Name

Shahenda

Last Name

Mahgoub

MiddleName

-

Affiliation

Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt

Email

shahendamahgoub@gmail.com

City

-

Orcid

-

Volume

1

Article Issue

3

Related Issue

599

Issue Date

2017-07-01

Receive Date

2016-12-12

Publish Date

2017-07-01

Page Start

137

Page End

142

Print ISSN

2357-0547

Online ISSN

2357-0539

Link

https://aprh.journals.ekb.eg/article_3362.html

Detail API

https://aprh.journals.ekb.eg/service?article_code=3362

Order

1

Type

Review Article

Type Code

358

Publication Type

Journal

Publication Title

Journal of Advanced Pharmacy Research

Publication Link

https://aprh.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023